About Mainavi Pharma
Mainavi Pharma was a Healthcare company based in Hyderabad (India) founded in 2020. It operates as a CDMO specializing in API manufacturing for pharmaceutical clients. It operates on a B2B model. Its Indian entity Mainavi Pharma Private Limited reported revenue of ₹9.6 Lakh. The company is recorded as dissolved. Its focus areas include Healthcare and Pharmaceuticals, Pharmaceutical Manufacturing, API Production and Contract Development. Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.
Company details
Mainavi Pharma, founded in 2020 in Hyderabad, India, focuses on healthcare and pharmaceuticals, pharmaceutical manufacturing, api production, and contract development. Operates as a CDMO specializing in API manufacturing for pharmaceutical clients. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Website mainavipharma.com
- Legal Name Mainavi Pharma Private Limited
- Date of Incorporation 02 Jun, 2020
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹9.6 Lakh
FY 2023 · -74% YoY
- Net Loss-₹1.7 Lakh
FY 2023 · -18% margin
- EBITDA₹13,611
FY 2023 · 1% margin
Associated legal entities of Mainavi Pharma
Mainavi Pharma operates through Mainavi Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mainavi Pharma Private Limited CIN U36990TG2020PTC140549 | Active | 02 Jun 2020 | Hyderabad, Telangana | ₹0.1 Cr | 7 | 2 | View details |
Board of directors of Mainavi Pharma Private Limited (Mainavi Pharma)
Mainavi Pharma Private Limited is the primary company behind Mainavi Pharma. The board of Mainavi Pharma Private Limited currently have 2 directors; the longest-serving is Srikanth Reddy Mogili, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Srikanth Reddy Mogili DIN 08751505 | Director | 02 Jun 2020 | 6 yrs 4 mo | Mainavi Pharma Private Limited |
| Mogili Prashanth Reddy DIN 08751504 | Managing Director | 02 Jun 2020 | 6 yrs 4 mo | Mainavi Pharma Private Limited |
Financials of Mainavi Pharma
Figures of Mainavi Pharma Private Limited, the primary company behind Mainavi Pharma, for FY 2023. Revenue was ₹9.6 Lakh (-74% year on year). Net loss was -₹1.7 Lakh (-18% margin). EBITDA was ₹13,611 (1% margin).
- ₹9.6 LakhRevenue · FY 2023 · -74% YoY
- -₹1.7 LakhNet loss · -18% margin
- ₹13,611EBITDA · 1% margin
- ₹20 LakhPaid-up capital
- 7Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Mainavi Pharma Private Limited are on its company page.
Detailed financial statements for Mainavi Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Mainavi Pharma
Mainavi Pharma has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed similar companies of Mainavi Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Mainavi Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mainavi Pharma
Mainavi Pharma was founded in 2020.
Mainavi Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Mainavi Pharma, Mainavi Pharma Private Limited, reported revenue of ₹9.6 Lakh for FY 2023, down 74% year on year.
Mainavi Pharma, founded in 2020 in Hyderabad, India, focuses on healthcare and pharmaceuticals, pharmaceutical manufacturing, api production, and contract development. Operates as a CDMO specializing in API manufacturing for pharmaceutical clients. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Mainavi Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Mainavi Pharma operates through Mainavi Pharma Private Limited.
The legal entities of Mainavi Pharma currently have 2 directors, including Srikanth Reddy Mogili, Mogili Prashanth Reddy.